X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Procter & Gamble Health with ADCOCK INGRAM HOLDINGS LTD. - S. Africa - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

PROCTER & GAMBLE HEALTH vs ADCOCK INGRAM (S. Africa) - Comparison Results

PROCTER & GAMBLE HEALTH     Change

Merck, the Indian arm of Merck KgaA (Germany), is a relatively smaller player among MNC pharma majors in the country. Merck has two business segments namely Pharmaceuticals and Chemicals. The pharmaceutical business, accounting for 68% of total sales... More

ADCOCK INGRAM (S. Africa)
   Change

Adcock Ingram is a leading South African pharmaceutical manufacturer, marketer and distributor. The company occupies 10% share of the private pharmaceutical market in South Africa with a strong presence in over-the-counter (OTC) brands. Adcock is als... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 PROCTER & GAMBLE HEALTH   ADCOCK INGRAM
EQUITY SHARE DATA
    PROCTER & GAMBLE HEALTH
Dec-18
ADCOCK INGRAM
Jun-14
PROCTER & GAMBLE HEALTH/
ADCOCK INGRAM
5-Yr Chart
Click to enlarge
High Rs3,549337-   
Low Rs1,301243-   
Sales per share (Unadj.) Rs511.4100.3-  
Earnings per share (Unadj.) Rs61.3-25.3-  
Cash flow per share (Unadj.) Rs74.0-20.9-  
Dividends per share (Unadj.) Rs440.000-  
Dividend yield (eoy) %18.10-  
Book value per share (Unadj.) Rs927.878.7-  
Shares outstanding (eoy) m16.60168.78-   
Bonus/Rights/Conversions ---  
Price / Sales ratio x4.72.9 163.9%   
Avg P/E ratio x39.6-11.5 -344.6%  
P/CF ratio (eoy) x32.8-13.9 -236.5%  
Price / Book Value ratio x2.63.7 70.9%  
Dividend payout %717.90-   
Avg Mkt Cap Rs m40,25748,973 82.2%   
No. of employees `0001.14.3 26.4%   
Total wages/salary Rs m1,3133,074 42.7%   
Avg. sales/employee Rs Th7,486.73,942.7 189.9%   
Avg. wages/employee Rs Th1,157.6716.0 161.7%   
Avg. net profit/employee Rs Th897.2-993.5 -90.3%   
INCOME DATA
Net Sales Rs m8,49016,926 50.2%  
Other income Rs m244119 205.8%   
Total revenues Rs m8,73417,045 51.2%   
Gross profit Rs m1,482-2,933 -50.5%  
Depreciation Rs m211731 28.9%   
Interest Rs m0458 0.0%   
Profit before tax Rs m1,514-4,004 -37.8%   
Minority Interest Rs m0-11 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m660-   
Tax Rs m563250 224.8%   
Profit after tax Rs m1,017-4,265 -23.9%  
Gross profit margin %17.5-17.3 -100.7%  
Effective tax rate %37.1-6.2 -594.5%   
Net profit margin %12.0-25.2 -47.6%  
BALANCE SHEET DATA
Current assets Rs m15,34312,397 123.8%   
Current liabilities Rs m1,9606,975 28.1%   
Net working cap to sales %157.632.0 492.1%  
Current ratio x7.81.8 440.4%  
Inventory Days Days49111 43.9%  
Debtors Days Days28124 23.0%  
Net fixed assets Rs m1,2097,226 16.7%   
Share capital Rs m16679 211.2%   
"Free" reserves Rs m15,2350-   
Net worth Rs m15,40113,285 115.9%   
Long term debt Rs m04,669 0.0%   
Total assets Rs m17,59525,097 70.1%  
Interest coverage xNM-7.7-  
Debt to equity ratio x00.4 0.0%  
Sales to assets ratio x0.50.7 71.5%   
Return on assets %5.8-15.2 -38.1%  
Return on equity %6.6-32.1 -20.6%  
Return on capital %10.3-19.8 -51.8%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m-2,7320-   
CASH FLOW
From Operations Rs m-1,3041,445 -90.2%  
From Investments Rs m12,697-444 -2,862.2%  
From Financial Activity Rs m-3014,237 -7.1%  
Net Cashflow Rs m11,0935,238 211.8%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for ADCOCK INGRAM (S. Africa) is South Africa Rand. All data has been converted at 4.65 Rs / ZAR

Compare PROCTER & GAMBLE HEALTH With: MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare PROCTER & GAMBLE HEALTH With: GSK PHARMA  CIPLA  DR. DATSONS LABS  FDC LTD.  LUPIN  



Today's Market

Sensex Ends 267 Points Lower; Metal and Capital Goods Stocks Witness Huge Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day deep in the red. At the closing bell, the BSE Sensex stood lower by 267 points (down 0.7%).

Related Views On News

PROCTER & GAMBLE HEALTH Announces Quarterly Results (1QFY20); Net Profit Up 34.3% (Quarterly Result Update)

Aug 13, 2019 | Updated on Aug 13, 2019

For the quarter ended June 2019, PROCTER & GAMBLE HEALTH has posted a net profit of Rs 441 m (up 34.3% YoY). Sales on the other hand came in at Rs 2 bn (up 6.1% YoY). Read on for a complete analysis of PROCTER & GAMBLE HEALTH's quarterly results.

PROCTER & GAMBLE HEALTH 2017-18 Annual Report Analysis (Annual Result Update)

Aug 8, 2019 | Updated on Aug 8, 2019

Here's an analysis of the annual report of PROCTER & GAMBLE HEALTH for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of PROCTER & GAMBLE HEALTH. Also includes updates on the valuation of PROCTER & GAMBLE HEALTH.

MERCK Announces Quarterly Results (4QFY19); Net Profit Up 79.2% (Quarterly Result Update)

May 13, 2019 | Updated on May 13, 2019

For the quarter ended March 2019, MERCK has posted a net profit of Rs 407 m (up 79.2% YoY). Sales on the other hand came in at Rs 2 bn (down 23.3% YoY). Read on for a complete analysis of MERCK's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

The Perfect Stock in the Rebirth of India (The 5 Minute Wrapup)

Aug 8, 2019

This debt-free, well-managed company is all set to soar.

This 60-Year Old Smallcap Company Could Be Our Next Recommendation (The 5 Minute Wrapup)

Aug 12, 2019

My experience at the recent AGM of this smallcap company which has financials of any FMCG major.

Super investor Pulak Prasad is Buying Stocks Big Time...and You Should Too (The 5 Minute Wrapup)

Aug 9, 2019

Here's why the relentless correction in the Indian stock markets has not unnerved the big investors.

Smallcaps that Will Outperform in the Market Rebound (Profit Hunter)

Aug 12, 2019

Only These Smallcaps Will Give Historic Returns in the Future.

Qatar is Rearing Cows...this is Good News for India

Aug 9, 2019

Qatar has turned around after the Saudi embargo. This is good news for India.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

PROCTER & GAMBLE HEALTH SHARE PRICE


Aug 21, 2019 (Close)

TRACK PROCTER & GAMBLE HEALTH

  • Track your investment in PROCTER & GAMBLE HEALTH with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON PROCTER & GAMBLE HEALTH

PROCTER & GAMBLE HEALTH - WYETH LTD COMPARISON

COMPARE PROCTER & GAMBLE HEALTH WITH

MARKET STATS